Equillium Inc reports results for the quarter ended in December - Earnings Summary

Equillium

25/03/2024 21:00

* Equillium Inc  EQ.OQ  reported a quarterly adjusted loss
of 7
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of 8
cents.  The mean expectation of four analysts for the quarter
was for a loss of 17 cents per share. Wall Street expected
results to range from -29 cents to -9 cents per share.
    * Revenue fell 41.6% to $9.21 million from a year ago;
analysts
expected $6.43 million. 
    * Equillium Inc's reported EPS for the quarter was a loss
of 7
cents​.
    * The company reported a quarterly loss of $2.33 million.
    * Equillium Inc shares had risen by 290.0% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is  "buy."

Wall Street's median 12-month price target for Equillium Inc is
$7.00 
This summary was machine generated from LSEG data March 25 at
09:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.17          -0.07          Beat
 Sep. 30 2023      -0.17          -0.11          Beat
 Jun. 30 2023      -0.17          -0.10          Beat
 Mar. 31 2023      -0.27          -0.11          Beat